Literature DB >> 2436465

Prenatal testing for maternal serum alpha-fetoprotein.

E J Schwager, B D Weiss.   

Abstract

The maternal serum alpha-fetoprotein level should be measured in all pregnant women at 16 to 20 weeks of gestation. Elevated alpha-fetoprotein levels require evaluation by ultrasonography and, sometimes, amniocentesis to detect neural tube defects. Low alpha-fetoprotein levels may be associated with chromosomal anomalies and should be evaluated with amniocentesis. Alpha-fetoprotein testing is cost-effective, and medicolegal liability makes it imperative to offer this screening test to all pregnant women.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436465

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  2 in total

1.  Screening in pregnancy.

Authors:  A Biringer
Journal:  Can Fam Physician       Date:  1988-09       Impact factor: 3.275

2.  Maternal serum screening.

Authors:  J C Carroll
Journal:  Can Fam Physician       Date:  1994-10       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.